16 July 2024
DLA Piper advises Zealand Pharma in US$1 billion equity offering
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Josh Kaufman Lead | DLA Piper | Partner | Capital Markets and Public Companies Advisory | Not stated |
| Steve Alicanti | DLA Piper | Partner | Not stated | New York |
| Frank Mugabi | DLA Piper | Partner | Not stated | Not stated |
| Andrew Wolfe | DLA Piper | Associate | Not stated | New York |
| John Wei | DLA Piper | Associate | Not stated | Boston |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 1bn (US$1 billion)
- What the figure measures
- Issue size
- Client
- Zealand PharmaIssuer
- Counterparties
- Not stated